Curriculum Vitae

DR. BENEDICT FRANCIS

Medical Lecturer
  • Department of Psychological Medicine
    Faculty of Medicine
  • benfrancis
  • 0379494895

BIOGRAPHY

 

Dr Benedict Francis is a consultant psychiatrist and a senior medical lecturer at the Faculty of Medicine, University of Malaya. He graduated from the Faculty of Medicine, University of Malaya and was selected for the Brightsparks scholarship to pursue his Masters in Psychological Medicine at his alma mater, the University of Malaya. Subsequently, he completed a fellowship program in Aged Healthcare Services at St Vincent’s Hospital, Melbourne, in 2019. Dr Benedict is one of the research leads at the Psychological Medicine Research Unit and has been involved as principal investigator and sub-investigator for several international, multi-centre clinical trials including the ESCAPE-TRD, REMISSIO, ASPIRE, SUSTAIN-3, ROUTE 6, and CONNEX-2 trials. He has also published in several international and regional peer-reviewed journals and presented in international congresses.

Dr Benedict has and continues to exhibit stellar leadership in his field. He was part of the Ministry of Health’s  National Advisory Board committee that drafted the guidelines for prescribing and dispensing Esketamine, a novel adjunct antidepressant treatment. In addition, he has been part of several steering commitees that paved new directions in mental health. For example, he was appointed to be part of the Southeast Asian steering committee to develop a patient decision aid for people living with schizophrenia. He is also part of the regional Asia Pacific steering commitee to develop a module for cognitive impairment associated with schizophrenia (CIAS). In 2023, he received the Excellent Service Award from the University of Malaya in recognition of his contributions. Dr Benedict is regarded as a Key Opinion Leader in the field of treatment resistant depression and schizophrenia and is a regular invited speaker at both local and regional events. He is actively involved in several associations at various levels. He is a life member of the Malaysian Psychiatric Association and a corresponding member of the European College of Neuropsychopharmacology. He is also a member of the Asian College of Neuropsychopharmacology. Recently he was inducted as Fellow of the Pacific Rim College of Psychiatrists. 

AREAS OF EXPERTISE

  • PSYCHIATRY
    Treatment resistant depression( adult and late-onset ), rapid-acting antidepressants, schizophrenia, old age psychiatry

ACADEMIC QUALIFICATION

  • MPM, (Psychological Medicine)
    Universiti Malaya (UM)
  • MBBS, (Medicine and Surgery)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Quality Manager
    01 Sep 2023 - 31 Dec 2026 (Department of Psychological Medicine, Faculty of Medicine)
  • Committee Members
    26 Jul 2024 - 26 Jul 2026 (Department)
  • Quality Manager
    06 Apr 2023 - 06 Jun 2025 (Department)
  • Task force member to develop a regional CME module for Cognitive Impairment Associated with Schizophrenia (CIAS)
    16 Dec 2023 - 31 Dec 2024 (International)
  • Programme Coordinator
    01 Aug 2022 - 01 Aug 2024 (Department of Psychological Medicine, Faculty of Medicine)
  • Committee Members
    01 Oct 2021 - 01 Jan 2024 (National)
  • Head Coordinator
    25 Oct 2023 - 27 Oct 2023 (National)
  • Task Force Member
    29 Apr 2022 - 03 Jun 2022 (International)

MEMBERSHIPS

  • FELLOW OF THE PACIFIC RIM COLLEGE OF PSYCHIATRIST, MEMBER
    2024 to present (International)
  • MEMBER OF ASIAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY, MEMBER
    2024 to present (International)
  • CORRESPONDING MEMBER OF THE EUROPEAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY (ECNP), MEMBER
    2024 to present (International)
  • STEERING COMMITTEE MEMBER FOR THE REGIONAL COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA (CIAS) CME DEVELOPMENT PROGRAMME, MEMBER
    2023 to 2024 (International)
  • ORDINARY LIFE MEMBER (MALAYSIAN PSYCHIATRIC ASSOCIATION ), MEMBER
    Since 2023 (National)
  • COUNCIL MEMBER, COMMITTEE MEMBER
    2021 to 2023 (National)
  • STEERING COMMITTEE MEMBER ON THE DEVELOPMENT OF A PATIENT DECISION AID FOR ANTIPSYCHOTIC FORMULATION TREATMENT OPTIONS, ADVISORY BOARD
    2022 to 2022 (International)
  • MEMBER OF MALAYSIAN PSYCHIATRIC ASSOCIATION , MEMBER
    2022 to 2022 (National)
  • MALAYSIAN PSYCHIATRIC ASSOCIATION , COMMITTEE MEMBER
    2021 to 2021 (National)
  • EARLY CAREER PSYCHIATRIST ASSOCIATION , 1ST VICE PRESIDENT
    2021 to 2021 (National)
  • MALAYSIAN MEDICAL ASSOCIATION , MEMBER
    2021 to 2021 (National)

AWARD AND STEWARDSHIP

  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2023 (University)
  • STEWARD Southeast Asia Faculty Member
    Janssen, 2023 (International)

PUBLICATIONS

Article in Journal
WoS
  1. Francis, Benedict; Ganasan, Vijay A. L.; Sulaiman, Abdul Rasyid Bin (2024). Brexpiprazole Attenuates Aggression, Suicidality and Substance Use in Borderline Personality Disorder: A Case Series, MEDICINA-LITHUANIA. 60(2). doi:10.3390/medicina60020283
  2. Franklin, Freddy; Rajamanikam, Arutchelvan; Phang, Wei Kit; Raju, Chandramathi Samudi; Gill, Jesjeet Singh; Francis, Benedict; Sy-Cherng Woon, Luke; Govind, Suresh Kumar (2024). Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia, SCIENTIFIC REPORTS. 14(1). doi:10.1038/s41598-023-50299-7
  3. Cheang, Yue Wen; Ng, Chong Guan; Petrus, Chiara Francine; Ramly, Siti Salwa; Teh, Ewe Eow; Ng, Yit Han; Francis, Benedict (2023). Negative religious coping mediates dementia caregiver burden and depression in a Malaysian setting, PSYCHOGERIATRICS. 23(4), 738-741. doi:10.1111/psyg.12989
  4. Reif, Andreas; Bitter, Istvan; Buyze, Jozefien; Cebulla, Kerstin; Frey, Richard; Fu, Dong-Jing; Ito, Tetsuro; Kambarov, Yerkebulan; Llorca, Pierre-Michel; Oliveira-Maia, Albino J.; Messer, Thomas; Mulhern-Haughey, Siobhan; Rive, Benoit; von Holt, Christian; Young, Allan H.; Godinov, Yordan (2023). Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression, NEW ENGLAND JOURNAL OF MEDICINE. 389(14), 1298-1309. doi:10.1056/NEJMoa2304145
  5. Sabki, Zuraida Ahmad; Kim, Lee Hui; Danaee, Mahmoud; Sulaiman, Ahmad Hatim; Razali, Khairul Arif; Koh, Ong Hui; Kanagasundram, Sharmilla; Kaur, Manveen; Azhar, Fatin Liyana; Francis, Benedict (2023). Assessment of Psychometric Properties of the Malay Version of the Brief Resilience Scale (BRS-M) among Non-Academic Staff Working from Home during COVID-19 in Malaysia, HEALTHCARE. 11(8). doi:10.3390/healthcare11081146
  6. Franklin, Freddy; Rajamanikam, Arutchelvan; Raju, Chandramathi Samudi; Gill, Jesjeet Singh; Francis, Benedict; Sy-Cherng, Luke Woon; Kumar, Suresh (2022). Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients, PARASITES & VECTORS. 15(1). doi:10.1186/s13071-022-05418-0
  7. Juhari, Johan Ariff; Gill, Jesjeet Singh; Francis, Benedict (2022). Coping Strategies and Mental Disorders among the LGBT+ Community in Malaysia, HEALTHCARE. 10(10). doi:10.3390/healthcare10101885
  8. Kumar, Mehul Kumar Narendra; Francis, Benedict; Hashim, Aili Hanim; Zainal, Nor Zuraida; Rashid, Rusdi Abdul; Ng, Chong Guan; Danaee, Mahmoud; Hussain, Nurulwafa; Sulaiman, Ahmad Hatim (2022). Prevalence of Anxiety and Depression among Psychiatric Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective, HEALTHCARE. 10(3). doi:10.3390/healthcare10030532
  9. Kumar, PR; Yee, A; Francis, B (2022). Impact of alcohol withdrawal training program on knowledge, attitude, and perception among healthcare providers in a hospital setting, JOURNAL OF SUBSTANCE USE. . doi:10.1080/14659891.2021.1897696
  10. Chow, S. K., Francis, B., Ng, Y. H., Naim, N., Beh, H. C., Ariffin, M. A. A., . . . Sulaiman, A. H. (2021). Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective. Healthcare, 9(1), 15. doi: 10.3390/healthcare9010079
  11. Francis, B., Ken, C. S., Han, N. Y., Ariffin, M. A. A., Yusuf, M. H. M., Wen, L. J., . . . Said, M. A. (2021). Religious Coping During the COVID-19 Pandemic: Gender, Occupational and Socio-economic Perspectives Among Malaysian Frontline Healthcare Workers. Alpha Psychiatry, 22(4), 194-199. doi: 10.5152/alphapsychiatry.2021.21185
  12. Kumar, PR; Yee, A; Francis, B; Danaee, M (2021). Adaptation and Validation of a scale to Assess Knowledge, Attitudes, and Perceptions of Healthcare Workers Towards Alcohol Withdrawal and Its Detection, INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION. . doi:10.1007/s11469-021-00562-7
  13. Loh, H. H., Francis, B., Lim, L. L., Lim, Q. H., Yee, A., & Loh, H. S. (2021). Improvement in mood symptoms after post-bariatric surgery among people with obesity: A systematic review and meta-analysis. Diabetes-Metabolism Research and Reviews, 37(8), 12. doi: 10.1002/dmrr.3458
  14. Nair, P., Gill, J. S., Sulaiman, A. H., Koh, O. H., & Francis, B. (2021). Mental Health Correlates Among Older Persons Residing in Malaysian Nursing Homes During the COVID-19 Pandemic. Asia-Pacific journal of public health, 33(8), 940-944. doi: 10.1177/10105395211032094
  15. Zaini, S., Sulaiman, A. H., Huri, H. Z., Koh, O. H., Gill, J. S., Francis, B., . . . Guan, N. C. (2021). Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana, 50(1), 161-170. doi: 10.17576/jsm-2021-5001-16
  16. Damodaran, I., Hui, K. O., Nordin, A. S. A., Yee, A., Gill, J. S., Francis, B., . . . Sulaiman, A. H. (2020). An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. Healthcare, 8(4), 13. doi: 10.3390/healthcare8040533
  17. Francis, B; Rizal, AJ; Sabki, ZA; Sulaiman, AH (2020). Remote Psychological First Aid (rPFA) in the time of Covid-19: A preliminary report of the Malaysian experience, ASIAN JOURNAL OF PSYCHIATRY. 54. doi:10.1016/j.ajp.2020.102240
  18. Francis, Benedict; Petrus, Chiara Francine; Wong, Haw Huo (2020). Electroconvulsive therapy in a 91-year old Asian lady with late onset bipolar mania, ASIAN JOURNAL OF PSYCHIATRY. 50. doi:10.1016/j.ajp.2020.101986
  19. Kaur, K., Sulaiman, A. H., Yoon, C. K., Hashim, A. H., Kaur, M., Hui, K. O., . . . Gill, J. S. (2020). Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. International journal of environmental research and public health, 17(18), 22. doi: 10.3390/ijerph17186730
  20. Loh, H. H., Yee, A., Loh, H. S., Kanagasundram, S., Francis, B., & Lim, L. L. (2020). Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones-International Journal of Endocrinology and Metabolism, 19(3), 413-423. doi: 10.1007/s42000-020-00210-0
  21. Sulaiman, A. H., Sabki, Z. A., Jaafa, M. J., Francis, B., Razali, K. A., Rizal, A. J., . . . Ng, C. G. (2020). Development of a Remote Psychological First Aid Protocol for Healthcare Workers Following the COVID-19 Pandemic in a University Teaching Hospital, Malaysia. Healthcare, 8(3), 11. doi: 10.3390/healthcare8030228
  22. Abd Rashid, Rusdi; Kanagasundram, Sharmilla; Danaee, Mahmoud; Majid, Hazreen Abdul; Sulaiman, Ahmad Hatim; Zahari, Muhammad Muhsin Ahmad; Ng, Chong Guan; Francis, Benedict; Husin, Wan Azlinda Irnee Wan; Su, Tin Tin (2019). The Prevalence of Smoking, Determinants and Chance of Psychological Problems among Smokers in an Urban Community Housing Project in Malaysia, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 16(10). doi:10.3390/ijerph16101762
  23. Francis, B.; Gill, J. S.; Sulaiman, A. H.; Petrus, C. F.; Koh, O. H. (2019). The antipsychotic property of neoadjuvant chemotherapy regime 5-flourouracil, epidoxorubicin and cyclophosphomide (FEC) in a patient with treatment resistant schizophrenia: a case study, EUROPEAN PSYCHIATRY. 56, S69-S69
  24. Francis, Benedict; Gill, Jesjeet Singh; Han, Ng Yit; Petrus, Chiara Francine; Azhar, Fatin Liyana; Sabki, Zuraida Ahmad; Said, Mas Ayu; Ong Hui, Koh; Guan, Ng Chong; Sulaiman, Ahmad Hatim (2019). Religious Coping, Religiosity, Depression and Anxiety among Medical Students in a Multi-Religious Setting, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 16(2). doi:10.3390/ijerph16020259
Scopus
  1. Franklin F., Rajamanikam A., Phang W.K., Raju C.S., Gill J.S., Francis B., Sy-Cherng Woon L., Govind S.K. (2024). Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia, Scientific Reports. 14(1). doi:10.1038/s41598-023-50299-7
  2. Ahmad Sabki Z., Kim L.H., Danaee M., Sulaiman A.H., Razali K.A., Koh O.H., Kanagasundram S., Kaur M., Azhar F.L., Francis B. (2023). Assessment of Psychometric Properties of the Malay Version of the Brief Resilience Scale (BRS-M) among Non-Academic Staff Working from Home during COVID-19 in Malaysia, Healthcare (Switzerland). 11(8). doi:10.3390/healthcare11081146
  3. Juhari J.A., Gill J.S., Francis B. (2022). Coping Strategies and Mental Disorders among the LGBT+ Community in Malaysia, Healthcare (Switzerland). 10(10). doi:10.3390/healthcare10101885
  4. Francis B., Guan N.C., Abousheishaa A.A. (2019). The use of agomelatine in anxiety disorders: A review, Current Topics in Pharmacology. 23, 103-112
Others
  1. Kumar, P. R., Yee, A., & Francis, B. (2021). Impact of alcohol withdrawal training program on knowledge, attitude, and perception among healthcare providers in a hospital setting. Journal of Substance Use, 1-6. doi: 10.1080/14659891.2021.1897696
  2. Loh, H.H., Francis, B., Lim, L. L., Lim, Q.H., Yee, A. and Loh, H.S. (2021), Improvement in mood symptoms post bariatric surgery among people with obesity: A systematic review and meta analysis. Diabetes Metab Res Rev
  3. Francis, B., Rizal A.J., Zuraida A.S, and Sulaiman A.H. (2020). Remote Psychological First Aid (rPFA) in the time of Covid-19: A preliminary report of the Malaysian experience. Asian journal of psychiatry.
  4. Francis, B., Ng, C. G., & Abousheishaa, A. A. (2019). The use of agomelatine in anxiety : A review. Current topics in pharmacology, 23.
  5. Francis, B., Jambunathan, S. T., & Gill, J. S. (2017). Asenapine in the treatment of trichotillomania with comorbid bipolar disorder: A case report. European Psychiatry, 41(S1), S683-S683.
  6. Francis, B., Jambunathan, S. T., Gill, J. S., & Wong, S. (2017). The blue-eyed man: A case of Waardenburg syndrome type 1 associated with mania and autistic spectrum disorder. European Psychiatry, 41(S1), S421-S422.
  7. Benedict F, Lim KS, Jambunathan ST, Hashim AH1.Antiepileptic-induced Psychosis as a Possible Predictor of Post-temporal Lobectomy Alternative Psychosis.East Asian Arch Psychiatry. 2016 Sep;26(3):109-11.
Books
  1. Abdullah A., Zain M.A, Ng, B.A., Francis, B., Lim, K.Q. ,Chua, S.H., Azhar, F.L., Gani, F.A., Zakaria, H., Samah, A.I., Lin, J.L., Zulkifli, A.N., Narayanan, N.N., Redzuan, I.N., Fadzil, A.N., Yeung, O.J., Zaini, S.(2019) Shared Decision Making in the use of antidepressants : A script for doctors. Servier Press

RESEARCH PROJECT

National
  1. 2022 - 2025, Others MOHE - Top 100 (IIRG)-HWB
    Development Of An Effective Dementia Care Toolkit For Relationship Centered Care Of Plwds ( Co-Researcher)
  2. 2023 - 2024, UM Living Labs @ UMSDC
    Unlocking the Keys Behind Greater Adoption and Adaptation Of E-Sports Exergaming as A Low Carbon Sport and Exercise Alternative ( Co-Researcher)
  3. 2022 - 2023, RU Geran - UMCares
    FITNESS BOOT CAMP: ENHANCING PHYSICAL HEALTH KNOWLEDGE, PERFORMANCE AND ENDURANCE USING ESPORTS EXERGAMING ( Co-Researcher)
  4. 2022 - 2024, Johnson & Johnson Sdn Bhd
    Open-label Long-Term Extension Study for Participants With Treatment-Resistant Major Depressive Disorder Who are Continuing Esketamine Nasal Spray Treatment From Study 54135419TRD3013 ( Co-Researcher)
  5. 2019 - 2022, Allergan Malaysia Sdn. Bhd.
    A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating The Efficacy, Safety, And Tolerability Of Cariprazine In A Dose-Reduction Paradigm In The Prevention Of Relapse In Bipolar I Disorder Patients Whose Current Episode Is Manic Or Depressive, With Or Without Mixed Features ( Co-Researcher)
  6. 2020 - 2022, Johnson & Johnson Sdn. Bhd.
    A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With Quetiapine Extended-Release in Adult and Elderly Participants With Treatment-Resistant Major Depressive Disorder Who are Continuing a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor ( Co-Researcher)
  7. 2018 - 2021, Johnson & Johnson Sdn. Bhd.
    A Double -blind, Randomized, Active -controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation ( Co-Researcher)
  8. 2020 - 2021, Allergan Malaysia Sdn. Bhd.
    A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER CLINICAL TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CARIPRAZINE IN A DOSE-REDUCTION PARADIGM IN THE PREVENTION OF RELAPSE IN PATIENTS WITH SCHIZOPHRENIA ( Co-Researcher)
Private
  1. 2023 - 2025, BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD.
    AN OPEN LABEL, SINGLE ARM, EXTENSION TRIAL TO EXAMINE LONG-TERM SAFETY OF BI 425809 ONCE DAILY IN PATIENTS WITH SCHIZOPHRENIA WHO HAVE COMPLETED PREVIOUS BI 425809 PHASE III TRIALS. (CONNEX-X) ( Principal Investigator(PI))
  2. 2022 - 2024, Boehringer Ingelheim Malaysia Sdn Bhd
    A phase III randomized, double-blind, placebo-controlled, parallel group trial to examine the efficacy and safety of BI 425809 once daily over 26 week treatment period in patients with schizophrenia (CONNEX-2) ( Co-Researcher)
  3. 2021 - 2023, NOVARTIS CORPORATION (M) SDN. BHD.
    A double-blind, placebo-controlled, randomized dose-ranging trial to investigate efficacy and safety of in-travenous MIJ821 infusion in addition to comprehensive standard of care on the rapid reduction of symptoms of Major Depressive Disorder in subjects who have suicidal ideation with intent ( Co-Researcher)
  4. 2020 - 2022, JOHNSON & JOHNSON SDN. BHD.
    A Randomized, Open-Label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With Quetiapine Extended-Release in Adult and Elderly Participants With Treatment-Resistant Major Depressive Disorder Who are Continuing a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor ( Co-Researcher)
  5. 2017 - 2021, JANSSEN, A DIVISION OF JOHNSON & JOHNSON SDN. BHD.
    An open-label long term extension safety study of intranasal esketamine in treatment-resistant Depression ( Co-Researcher)
International
  1. 2021 - 2023, Private Funding
    A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With Quetiapine Extended-Release in Adult and Elderly Participants With Treatment-Resistant Major Depressive Disorder Who Are Continuing a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor ( Consultant)
  2. 2021 - 2023, Private Funding
    A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in a Dose-reduction Paradigm in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features ( Co-Researcher)
  3. 2021 - 2022, JANSSEN PHARMACEUTICA NV
    A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to AntiDepressants in Adult and Elderly Patients With Major Depressive Disorder with Insomnia Symptoms Who Have Responded Inadequately to Antidepressants Therapy ( Co-Researcher)
  4. 2020 - 2022, Private Funding
    A double-blind, placebo-controlled, randomized withdrawal, multicentre clinical trial evaluating the efficacy, safety, and tolerability of Cariprazine in a dose-reduction paradigm in the prevention of relapse in patients with Schizophrenia ( Consultant)
  5. 2018 - 2019, Private Funding
    A double-blind, randomized, active-controlled, parallel-group study of Paliperidone Palmitate 6 months formulation. ( Consultant)
  6. 2015 - 2018, SUMITOMO DAINIPPON PHARMA CO., LTD.
    CONFIRMATORY STUDY OF DSP-5423P IN PATIENTS WITH SCHIZOPHRENIA ( Co-Researcher)
  7. 2015 - 2016, Private Funding
    Confirmatory study of DSP-5423P in patients with Schizophrenia ( Consultant)
University
  1. 2023 - 2025, University Grant
    Development of a Novel Malaysian Browser Game-Based Therapy to Treat Adults with Depression ( Principal Investigator(PI))

PAPER PRESENTED

PLENARY SPEAKER
  1. Functional recovery in schizophrenia, National Mental Health Meeting (NMHM) 2022, J&J (National) (13 Aug 2022 - 14 Aug 2022)
INVITED SPEAKER
  1. Treatment strategies for Treatment-Resistant Depression & Major Depressive Disorder with suicidal ideations, 12th SPEAK Round Table Discussion, J&J (National) (27 Jun 2024 - 27 Jun 2024)
  2. Combatting loneliness and social isolation, 2nd National Conference on Mental Health and Wellbeing Across Generations, NCMW (National) (11 May 2024 - 11 May 2024)
  3. BPSD in dementia and late life, Masterclass, Luye Pharma (National) (27 Apr 2024 - 27 Apr 2024)
  4. The Malaysian experience : Benefits of longer-acting injectables, Trinza Expert Talk, J&J (National) (24 Apr 2024 - 24 Apr 2024)
  5. Broad spectrum action of cariprazine in Bipolar Disorder, Round Table Discussion, Mitsubishi Tanabe Pharma (National) (15 Apr 2024 - 15 Apr 2024)
  6. Real world experience of Esketamine and how it fits into the treatment paradigm of major depressive disorder, IMH grand rounds, J&J (International) (27 Oct 2023 - 27 Oct 2023)
  7. Treating the full spectum of Bipolar Disorders : Targeting key symptoms of mania, mixed features and depression, Round Table Discussion, Mitsubishi Tanabe Pharma (National) (27 Sep 2023 - 27 Sep 2023)
  8. Challenges in applying shared decision making in clinical practice, Master Class XII, Servier (National) (29 Jul 2023 - 29 Jul 2023)
  9. The role of Quetiapine XR in Major Depressive Disorder, Luye Webinar, Luye Pharma (National) (27 Jun 2023 - 27 Jun 2023)
  10. ESCAPE TRD: Treatment Paradigm Shift in TRD, STEWARD SEA Summit 2023, Janssen (International) (13 May 2023 - 14 May 2023)
  11. Cariprazine : Case study , Mitsubishi Re-embracing life expert seminar 2023, Mitsubishi (National) (25 Feb 2023 - 25 Feb 2023)
  12. Partial Agonist for functional recovery: The role of Abilify Maintena , Lundbeck CME, Lundbeck  (University) (09 Feb 2023 - 09 Feb 2023)
  13. Functional recovery in depression, Masterclass XI - Meet the Experts, Servier (National) (18 Jun 2022 - 19 Jun 2022)
  14. Healthcare worker role play session for paliperidone palmitate and Esketamine, Accelerated Customer Engagement Program, J&J (International) (30 May 2022 - 31 Aug 2022)
  15. Physical or social distancing : Implications for mental health, 10th Malaysian Healthy Ageing Conference , MHAS (National) (15 Mar 2022 - 17 Mar 2022)
  16. Dementia(BPSD) and caregiver stress, 10th Malaysian Healthy Ageing Society , MHAS (National) (15 Mar 2022 - 17 Mar 2022)
  17. Highlights from major meta-analysis studies, MPA Servier Best Postgraduate Research Award 2022, Servier (National) (22 Jan 2022 - 22 Jan 2022)
  18. The role of Rexulti in the inadequate response in MDD, The role of Rexulti in the inadequate response in MDD, Lundbeck (University) (02 Sep 2021 - 02 Sep 2021)
  19. Long Acting SGA Antipsychotics in early phase schizophrenia, Long Acting SGA Antipsychotics in early phase schizophrenia, J&J (International) (27 Aug 2021 - 27 Aug 2021)
  20. Depression workshop : Approach Brilliantly 2021, Depression workshop : Approach Brilliantly 2021, Lundbeck (National) (21 Aug 2021 - 21 Aug 2021)
  21. Esketamine in the management of mood disorders : ESKIMOOD, Patient case discussion , J&J (National) (17 Jul 2021 - 17 Jul 2021)
  22. Depression and anxiety : two sides of the same coin ?, Future Expert Training(FET) Seminar, Servier (National) (29 May 2021 - 29 May 2021)
  23. Role of esketamine in treatment resistant depression, STEWARD Masterclass : Hand in hand for psychiatry , J&J (National) (20 Mar 2021 - 20 Mar 2021)
ORAL PRESENTER
  1. Hikikomori : A Malaysian perspective, 20th International Congress of the Pacific Rim College of Psychiatrist, PRCP (International) (13 Oct 2023 - 15 Oct 2023)
  2. Antiepileptic-induced psychosis is a possible predictor for post temporal lobectomy alternalte psychosis Abstract presentation, 16th Annual Meeting of the International College of Geriatric Psychoneuropharmacology(ICGNP) at Athens, Greece, International College of Geriatric Psychoneuropharmacology(ICGNP) (International) (06 Oct 2016 - 08 Oct 2016)
POSTER PRESENTER
  1. The antipsychotic property of neoadjuvant chemotherapy regime 5-flourouracil, epidoxorubicin and cyclophosphomide (FEC) in a patient with treatment resistant schizophrenia : a case study, 27th European Psychiatric Association (EPA) Congress, Warsaw, Poland (6-9th April 2019), European Psychiatric Association  (International) (06 Apr 2019 - 09 Apr 2019)
PRESENTER
  1. Correlates and Prevalence of Anxiety Disorders Among Women With Polycystic Ovarian Syndrome (PCOS): A Malaysian Cross-sectional Study, 26th European Psychiatric Association (EPA) Congress, Nice, France, European Psychiatric Congress (International) (03 Mar 2018 - 06 Mar 2018)
  2. Depressive Disorders and Sexual Functioning Among Malaysian Women With Polycystic Ovarian Syndrome (PCOS): A Cross-sectional Study, 26th European Psychiatric Association (EPA) Congress, Nice, France , European Psychiatric Congress (International) (03 Mar 2018 - 06 Mar 2018)
  3. Asenapine in the Treatment of Trichotillomania with Comorbid Bipolar Disorder: a Case Report , Poster presentation at the 25th European Psychiatric Association (EPA) Congress, Florence, Italy (1-4th April 2017), European Psychiatric Association (International) (01 Apr 2017 - 04 Apr 2017)
  4. The Blue-eyed Man : a Case of Waardenburg Syndrome Type 1 Associated with Mania and Autistic Spectrum Disorder , Poster presentation at the 25th European Psychiatric Association (EPA) Congress at Florence, Italy , European Psychiatric Congress (International) (01 Apr 2017 - 04 Apr 2017)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2024) Reviewer for Article : Protective and Risk Factors for Suicidal Behaviour in Self-Declared Lgbtiq+Adolescents, International, (Reviewer)
  2. (2023) Examiner for Thesis Dissertation for Mpm Part 3 November 2023, University, (Internal Examiner)
  3. (2023) Thesis Defence Examiner : Cognitive Function Among Methadone Assisted Treatment Patients in Malaysia, National, (Internal Examiner)
  4. (2023) Candidature Defence : The Effect of Online Psychoeducation Program On Panic Symptom Severity, Anxiety and Quality of Life Among People Experiencing Panic Attacks in Egypt, University, (Internal Examiner)
  5. (2023) Examiner for The Parts 1 & 2 Theory Examination November 2023, National, (External Examiner)
  6. (2023) Peer Review : Effect of Gastrointestinal Symptoms and Skipping Breakfast On Anxiety and Depression in Quarantined Chinese College Students During The Covid-19 Pandemic : a Cross-Sectional Survey, International, (Reviewer)
  7. (2023) Dissertation Viva Examination Part 3 May 2023, University, (Internal Examiner)
  8. (2023) Examiner for Conjoint Board Theory Paper Parts 1 & 2 May 2023, National, (External Examiner)
  9. (2023) Peer Review : Management Support for Healthcare Worker's Mental Health and Burnout During The Covid-19 Pandemic, International, (Reviewer)
  10. (2023) Peer Review : Stress During The Covid-19 Pandemic Moderates Pain Perception and Oxytocin Levels, International, (Reviewer)
  11. (2023) Peer Review: Work Stress as a Consequence of The Covid-19 Pandemic :a Systematic Review, International, (Reviewer)
  12. (2022) Peer Review of Article : "Older Adults Access to Mental Health and Social Care Services During Covid-19 Restrictions in Western Australia", International, (External Assessor)
  13. (2022) Peer Review of Article : " Older Adults Access to Mental Health and Social Care Services During Covid-19 Restrictions in Western Australia", International, (External Assessor)
  14. (2022) Peer Reviewer for Article : Resilience and Depression Mediated Pathways from Social Support to Suicidal Ideation Among Undergraduates During The Covid-19 Campus Lockdown in China, International, (Reviewer)
  15. (2022) Peer Reviewer for Article : Identification of Cognitive Strategies Used by Cancer Patients as a Basis for Psychological Self-Support During Oncological Therapy, International, (Reviewer)
  16. (2022) Peer Review of Article : Effects of Covid-19 On Adolescent Mental Health and Internet Use by Ethnicity and Gender : a Mixed-Method Study, National, (Reviewer)
  17. (2022) Peer Review for Article : Psychological Interventions in a Pandemic Emergency : a Systematic Review and Meta-Analysis, International, (Reviewer)
  18. (2022) Assessor for Phd Proposal Defense : The Impact of Covid-19 On Mental Health of Older People, University, (Internal Assessor)
  19. (2022) Peer Reviewer for Article : Examining Sleep, Anxiety and Physical Activity as Predictors of Depression Among University Students from Saudi Arabia During The Second Wave of Covid-19, International, (Reviewer)
  20. (2022) Peer Reviewer of Article : The Interaction Effect of Parental Rejection and Oxytocin Receptor Gene Polymorphism On Depression: a Cross-Cultural Study in Non-Clinical Samples, International, (Reviewer)
  21. (2022) Peer Reviewer of Article : Gender Differences in Coping, Depression, and Anxiety in Patients With Thoracic Cancer, International, (Reviewer)
  22. (2021) Peer Reviewer for Manuscript : Relationship Between Stress Response and Depression in Vocational Medical School Students in The Covid-19 Epidemic: a Moderated Mediation Model, International, (Reviewer)
  23. (2021) Peer Reviewer for Article : a Web-Based Survey of General Publics Experience and View On Clinical Appointment Structure in Malaysian Healthcare System, International, (Reviewer)
  24. (2021) Peer Reviewer for The Article " Integrating Social Support Into Interventions Among The Elderly in Nursing Homes: a Scoping Review Protocol ", International, (External Assessor)
Contribution to external organisation
  1. (2022) Steering Comittee Member On Development of a Patient Decision Aid for Antipsychotic Formulation Treatment Options, International, (Expert Advisor)
Contribution to event
  1. (2023) Steering Committee Member for The Regional Cias Cme Series, International, (Panelist/Moderator)
  2. (2022) Speaker for Servier's Masterclass Xi, National, (Panelist/Moderator)
  3. (2021) Invited Speaker for The Webinar " Mood Changes and Daily Activities During Covid-19", National, (Panelist/Moderator)
  4. (2021) Panelist for Online Forum On Mood Changes During The Pandemic Among Older Adults, National, (Panelist/Moderator)
  5. (2021) Debater : The Benefits of Lai in Early Schizophrenia Outweighs Its Risks, International, (Panelist/Moderator)
Media appearance
  1. (2022) Panelist for Tv3's Wanita Hari Ini : Apa Yang Kanak-Kanak Pendam, National, (Panelist/Moderator)
  2. (2022) Panelist for Rtm's Selamat Pagi Malaysia : Cegah Bunuh Diri, National, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
  1. (2024) EFFECTS OF DEMENTIA BEHAVIORAL EDUCATIONAL PROGRAM ON CAREGIVER BURDEN, SELF-EFFICACY AND MENTAL HEALTH OF CARERS, NORAIZAL BINTI MOHD NOOR
Under Graduate Students
  1. (2022) Practices, Audrey Loh Joe Chii, Muhammad Verka Danial Bin Nagi
  2. (2021) Psychological Medicine Posting G Stream I
  3. (2021) Psychological Medicine Posting F Stream 4

TEACHING

Master
  1. (2024) NA - Master of Psychological Medicine Tutorials
  2. (2023) - - Master of Psychological Medicine Tutorials
  3. (2022) NA - Mpm Seminar and Tutorials
  4. (2021) - - Mpm
  5. (2021) - - Postgraduate and Colloqium
Bachelor
  1. (2024) NA - Ummp Seminars and Tutorials
  2. (2023) NA - Ummp Seminars and Tutorials
  3. (2022) NA - Ummp Tutorials and Seminars
  4. (2021) UMMP - Universiti Malaya Medical Programme
  5. (2021) Case Conference : Bipolar Disorder
  6. (2021) Tutorial Posting F, Stream 4
  7. (2021) NA - Case Conference :Bipolar Disorder
  8. (2021) NA - Tutorial Posting G, Stream 1

PATENT/IPR

  • Antidepressant Patient Decision Aid, How to choose depression medication with your Doctor?
    COPYRIGHT

SOCIAL RESPONSIBILITY ACTIVITIES

  • Mental Health Volunteer At The Selangor Mental Health Association (Smha), (02 Nov 2023 - 31 Oct 2025) (National)
  • Psychiatrist in The Archdiocesan Mental Health Ministry , Providing Voluntary Professional Mental Health Service for Individuals With Mental Health Crisis., (01 Jan 2023 - 31 Dec 2025) (National)
  • Disseminating Information for The Public On Mood Changes During The Pandemic, (02 Oct 2021 - 02 Oct 2021) (National)
  • Psychological Support Team (Pst) Member Ppum During The Covid-19 Pandemic, (30 Mar 2020 - 30 Apr 2021)
  • National Taskforce Member for The Sungai Kim Kim Disaster 2019, (01 Jul 2019 - 31 Oct 2019)

COURSE ATTENDED

Internal / External Course
CONFERENCE
  1. 26TH MALAYSIAN CONFERENCE OF PSYCHOLOGICAL MEDICINE (MCPM) 2022, Sheraton Imperial Kuala Lumpur (09 Sep 2022 - 11 Sep 2022)
  2. CONNEX ASKAN INVESTIGATOR'S MEETING, Le Meridien Hotel, Kl (16 Jun 2023 - 16 Jun 2023)
  3. CONNEX -1/-2 ASEAN INVESTIGATOR MEETING, Singapore (06 Oct 2022 - 07 Oct 2022)
  4. ASIA PACIFIC NEURON CONFERENCE 2023, Royale Chulan Hotel, Kl (10 Jul 2023 - 11 Jul 2023)